Neurent Medical is dedicated to developing highly innovative non-surgical interventions that treat chronic inflammatory Sino-Nasal diseases. The privately held, venture backed company is based in Galway Ireland. Neurent Medical was founded by CEO Brian Shields and CTO David Townley, culminating from their work at the BioInnovate Ireland program at the National University, Galway.

Leadership Team and Board of Directors
Brian Shields
Co-founder & CEO
Board Member
View Bio
David Townley
Co-founder & CTO
Board Member

View Bio
Declan Daly
Chief Financial Officer
View Bio
Karen Peterson
VP of Clinical, Regulatory & Quality
View Bio
Brent Shreiner
VP Sales
View Bio
Mark Fletcher
Chairman of the Board
Former President, Medtronic Surgical Technologies
View Bio
Justin Lynch
Board Member
Partner & CFO,
Fountain Healthcare Partners
View Bio
Eamon Brady
Board Member

View Bio
Drew Burdon
Board Member

View Bio
Gerry Maguire
General Partner
Atlantic Bridge

View Bio
Recent News

Stay up to date with the latest news from Neurent Medical

New Data show NEUROMARK® Chronic Rhinitis Treatment Offers Significant Symptom Improvements

21st March 2023

Significant Symptom Improvements

Neurent Medical Announces Limited Market Release of NEUROMARK® System to Treat Chronic Rhinitis

3rd February 2023

Press release about Limited Release

Neurent Medical Receives FDA Clearance for NEUROMARK, a Novel Multi-Point Nerve Disruption Treatment for Chronic Rhinitis

18th November 2021

Press release about FDA Clearance